期刊文献+

医疗机构临床实验室自建检测方法流程与管理专家共识

Expert consensus on the workflow and management of laboratory developed tests in medical institutions
原文传递
导出
摘要 随着临床医学和检验医学的不断发展,实验室自建检测方法(包括自制试剂等)流程与管理规范化成为医疗机构的迫切需求。北京医学会检验医学分会、上海市医学会检验医学专科分会组织专家进行了政策学习、文献归纳、专业讨论与总结,并形成该专家共识。该共识基于自建检测的质量、风险、性能三方面核心关键要素,围绕术语、研发与产品准备、检验流程、登记备案、督查、检验前中后环节、转化应用与推广等内容给出了共识性建议,以期为医疗机构开展相应工作提供参考。 With the continuous development of clinical medicine and laboratory medicine,the normalization of workflow and management of laboratory developed tests(LDTs)(including self-made reagents,etc.)has become anxious needs for medical institutions.The Laboratory Medicine Society of Beijing Medical Association and the Laboratory Medicine Society of Shanghai Medical Association organized experts to conduct policy learning,literature review,professional discussion and summary,and formed this expert consensus.Based on the core key elements of quality,risk,and performance of LDTs,this consensus provides consensus on terminology,research and development,product preparation,inspection process,registration and documentation,supervision,pre-,mid-,post-analytical processes,transformative application and promotion,etc.It is expected to give reference for medical institutions carrying out corresponding work.
作者 北京医学会检验医学分会 上海市医学会检验医学专科分会 王辉 王培昌 王学锋 曹永彤 陈宏斌 崔巍 傅启华 郭林 郭玮 李传保 李海霞 卢仁泉 宁永忠 邱玲 周洲 Laboratory Medicine Society of Beijing Medical Association;Laboratory Medicine Society of Shanghai Medical Association;Wang Hui;Wang Peichang;Wang Xuefeng
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2024年第9期1005-1012,共8页 Chinese Journal of Laboratory Medicine
关键词 实验室 医院 诊疗工作管理 医学 实验室自建检测 专家共识 Laboratory,hospital Practice management,medical Laboratory developed tests Expert consensus
  • 相关文献

参考文献4

二级参考文献16

  • 1Flannery E, Danzis S. FDA plans to regulate laboratory developed tests as devices. Journal of Medical Device Regulation. [ EB/ OL ]. [ 2010-8 ] . http://www, coy. com/files/Publication/ 516 fd2e9-4edc-4 deO-8Odb-15 ba723 fb51 e/Presentation/ PublicationAttaehment/a5 d221 b6-600b-4be7-8cOa- 217tb00f3688/FDA% 20Plans% 20to% 20Regulate% 20Laboratory% 20Developed% 20Tests% 20as% 20Devices. pdf.
  • 2US Food and Drug Administration. Draft guidance for industry, food and drug administration staff, and clinical laboratories: framework for regulatory oversight of laboratory developed tests (LDT) . [ EB/OL ] . [ 2014-10-3 ] http ://www. fda. gov/ downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/U CM416685. pdf.
  • 3Department of Health and Human Services, Food and DrugAdministration. Optimizing FDA's regulatory oversight of next generation sequencing diagnostic tests-preliminary discussion paper. [ EB/OL ] . [ 2014-12-9 ] . http://www, fda. gov/ downloads/medicaldevices/newsevents/workshops conferences/ ucm 427869. pdf.
  • 4Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health Optimizing FDA' s regulatory oversight of next-generation sequencing diagnostic tests. [ EB/OL]. [2015-2-20]. http:// www. fda. gov/downloads/MedicalDevices/NewsEvents! WorkshopsConferences/UCM439974. pdf.
  • 5Shuren J, Conway PK. FDA and CMS form task force on LDT quality requirements. [ EB/OL ] . [ 2015-4-16 ] . http:// blogs, fda. gov/fdavoice/index, php/2015/04/fda-and-cms-form- task -force -on -ldt-quality -requirements/.
  • 6Emily Wasserman. FDA calls for beefed-up oversight of lab- developed tests. [ EB/OL ] . [ 2015-11-17 ] . http:// www. fiercemedicaldevices, conr/story/fda-calls-beefed-oversight- lab-developed-tests/2015 -11-17.
  • 7Tazawa Y. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan. Breast Cancer, 2015, Jan 22. [ Epub ahead of print].
  • 8宋彦强,李凤云,李玮,夏黎黎,倪君君.生物样品中儿茶酚胺类物质分析方法的研究进展[J].中国卫生检验杂志,2013,23(5):1339-1341. 被引量:6
  • 9刘维薇,郑特,徐科,关明.国外实验室自建项目管理带给我们的启示[J].中华临床实验室管理电子杂志,2014,2(3):1-4. 被引量:6
  • 10潘柏申.我国医学检验实验室自建检测方法发展与管理的期望[J].中华检验医学杂志,2016,39(1):1-3. 被引量:16

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部